Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xenon is a colorless, odorless, tasteless noble gas that is chemically non-reactive and naturally present in the atmosphere. In medicine, it is used as an inhaled anesthetic for general anesthesia due to its rapid onset and offset of action, stable cardiovascular effects (maintaining blood pressure and heart rate), and neuroprotective properties. Xenon acts as an NMDA receptor antagonist, which contributes to its anesthetic and neuroprotective effects. It is also used in diagnostic imaging—specifically as a radioactive agent (xenon-133) for lung function evaluation and cerebral blood flow assessment, or as hyperpolarized xenon-129 for advanced MRI lung imaging[2][5][6]. Unlike other inhalational anesthetics, xenon does not contribute to greenhouse gas emissions or environmental harm[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xenon.